Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents
申请人:The Dupont Merck Pharmaceutical Company
公开号:US05879657A1
公开(公告)日:1999-03-09
This invention provides novel radiopharmaceuticals that are radiolabeled cyclic compounds containing carbocyclic or heterocyclic ring systems which act as antagonists of the platelet glycoprotein IIb/IIIa complex; to methods of using said radiopharmaceuticals as imaging agents for the diagnosis of arterial and venous thrombi; to novel reagents for the preparation of said radiopharmaceuticals; and to kits comprising said reagents.